Risk factors for parapneumonic effusion in community-asquired pneumonia

O. Brodskaya (Moscow, Russian Federation), A. Ball (Moscow, Russian Federation), M. Kevorkova (Moscow, Russian Federation), D. Glazova (Moscow, Russian Federation)

Source: International Congress 2019 – Pleural infection and complicated pneumonia
Session: Pleural infection and complicated pneumonia
Session type: Poster Discussion
Number: 3848
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Brodskaya (Moscow, Russian Federation), A. Ball (Moscow, Russian Federation), M. Kevorkova (Moscow, Russian Federation), D. Glazova (Moscow, Russian Federation). Risk factors for parapneumonic effusion in community-asquired pneumonia. 3848

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictive factors, microbiology and outcome of patients with parapneumonic effusion
Source: Eur Respir J 2011; 38: 1173-1179
Year: 2011



Management of parapneumonic effusion and empyema in children
Source: Eur Respir J 2002; 20: Suppl. 38, 589s
Year: 2002

Empyema and parapneumonic pleural effusion. Prognostic factors about 109 patients
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009


Risk factors associated to surgical treatment of parapneumonic effusion and empyema
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013


Treatment results of patients with complicated parapneumonic effusion and empyema
Source: Eur Respir J 2002; 20: Suppl. 38, 358s
Year: 2002

Predictors of outcome in parapneumonic pleural effusions in children
Source: Eur Respir J 2001; 18: Suppl. 33, 171s
Year: 2001

Lung function of preschoolers with parapneumonic effusions complicating community acquired pneumonia
Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae
Year: 2011


Parapneumonic effusion and empyema
Source: Respipedia Article
Year: 2017

Lung function in children post parapneumonic effusion and empyema
Source: Eur Respir J 2002; 20: Suppl. 38, 590s
Year: 2002

Update on the management of parapneumonic pleural effusions
Source: Virtual Congress 2021 – Spanish/Portuguese programme 2021
Year: 2021


Decreasing incidence of parapneumonic pleural effusions (PPE) in children
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016


Late period pulmonary functions of the patients who were treated for parapneumonic effusion and empyema
Source: Eur Respir J 2006; 28: Suppl. 50, 488s
Year: 2006

Protein profiling of pleural fluid in guiding management of infectious parapneumonic effusion in children
Source: International Congress 2015 – Paediatric pulmonary infections
Year: 2015

Pleural empyema in acute bacterial pneumonia in children
Source: Eur Respir J 2004; 24: Suppl. 48, 715s
Year: 2004

Role of C-reactive protein in discriminating complicated and uncomplicated parapneumonic effusion from malignant and tuberculous pleural effusion
Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status
Year: 2021


Mortality and bacteriology in pleural empyema
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009


Role of pulmonary scintigraphy in children post parapneumonic effusion and empyema
Source: Eur Respir J 2001; 18: Suppl. 33, 170s
Year: 2001